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Abstract
Inoculation theory offers a framework for protecting individuals against challenges to an
existing attitude, belief, or state. Despite the prevalence and damaging effects of public
speaking anxiety, inoculation strategies have yet to be used to help individuals remain calm
before and during public speaking. We aimed to test the effectiveness of an inoculation mes-
sage for reducing the onset of public speaking anxiety, and helping presenters interpret their
speech-related anxiety more positively. Participants (Mage = 20.14, SD = 2.72) received
either an inoculation (n = 102) or control (n = 128) message prior to engaging a public speak-
ing task and reported a range of anxiety-related perceptions. Accounting for personality
characteristics and perceptions of task importance, and relative to control participants,
those who received the inoculation message reported significantly lower pre-task anxiety,
and following the task, reported that they had experienced lower somatic anxiety, and that
the inoculation message had caused them to view their nerves in a less debilitating light.
Inoculation messages may be an effective strategy for helping participants reframe and
reduce their apprehension about public speaking, and investigating their efficacy in other
stress-inducing contexts may be worthwhile.
Introduction
Public speaking is often viewed as a highly threatening and anxiety-inducing task [1,2]. It has
been reported, for example, that public speaking anxiety is the most common social fear
among the general population [3], and that concerns regarding public speaking can impede
one’s work, social, and educational functioning [4,5]. Indeed, at its most severe, public speak-
ing anxiety may be classified as a form of social anxiety disorder [6,7]; the recent fifth edition
of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5 [6]), for example,
includes a ‘performance only’ specifier that is restricted to anxiety regarding speaking or per-
forming in public. In light of the prevalence of public speaking anxiety and the deleterious
implications with which it is associated, the aim of this experiment was to test the effectiveness
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of a novel messaging strategy designed to reduce the onset of public speaking anxiety, as well
as to help presenters interpret their speech-related anxiety in a more positive light.
Sustained research attention has been devoted to studying the origins of public speaking
anxiety [8], and desensitization procedures, cognitive modification therapies, and/or skills
training approaches have also been implemented with the goal of helping presenters overcome
(or reduce) their anxiety [8,9]. For example, treatment methods that have been successful in
reducing self-reported anxiety levels include stress inoculation training [10], cognitive behav-
ioral therapy [11], confidence-raising techniques [12], video-based methods [13], attention
modification programs [14], information provision and education strategies [15,16], virtual
reality training [17], and hypnosis-based approaches [18].
In light of the effectiveness of these interventions, one might reasonably question whether
further investigation of public speaking anxiety treatment is required. There are, however, two
key considerations that encourage additional research in this area, and that provided the ratio-
nale for this investigation. First, although these treatments have largely been effective, wide-
spread implementation may be difficult to achieve in many instances. For example, a number
of these methods are relatively time- and/or labor-intensive, and require repeat attendance,
trained interventionists, and/or one-to-one administration (e.g., stress inoculation training,
hypnosis-based methods, curriculum-based education). Similarly, other methods are not cost-
effective or well-suited to mass dissemination (e.g., virtual reality training). Accordingly, it is
important to explore cost-effective, standardized methods that are suited for widespread dis-
semination and do not rely on the capacity/availability of a third party. Related to the notion
of developing standardized treatments, it is also noteworthy that the anxiety-reducing strate-
gies outlined in the available literature have typically not been devised using established mes-
saging/persuasion principles (i.e., by drawing from theoretical principles that inform us about
how to generate persuasive messages that can shape or sustain desired states and attitudes).
Persuasion frameworks provide guidance on the development of effective message structure
and content [19], and despite their potential for use in relation to public speaking preparation,
these frameworks have been absent from many of the previously published studies. These con-
siderations (i.e., an easily administered, standardized, cost-effective method, suitable for mass
dissemination and not reliant on an interventionist) were foremost in informing the develop-
ment of our experimental manipulation, and we sought to ensure that our approach was scaf-
folded by established persuasion guidelines.
In addition to the abovementioned design considerations, studies focusing on public speak-
ing anxiety treatment have not traditionally embraced all that is known about both the struc-
ture and interpretation of performance anxiety. It is acknowledged in public speaking [5] and
other settings [20] that anxiety may consist of a physiological/somatic component (e.g., trem-
bling body/voice, muscle tension) alongside a cognitive/worry component (e.g., self-doubt,
fear of one’s anxiety being visible to the audience). Despite this perspective, some of the docu-
mented attempts to alleviate public speaking anxiety have failed to differentially or explicitly
account for both somatic and cognitive components within their assessment [11,14,16].
More importantly, although these studies have been successful in reducing individuals’ self-
reported anxiety, it is also important to account for individuals’ interpretations about the
effects of any residual nerves. Anxiety interpretation (or reappraisal) research within a range
of social and performance situations [21–24] has stressed the importance of understanding not
only the level (or magnitude) of a person’s anxiety, but also the way (i.e., direction) in which
that anxiety is appraised by the focal person. It has been demonstrated that, depending on
one’s mindset and perception of control, a given amount of anxiety need not be viewed as
debilitative (i.e., damaging) for one’s functioning, and may in fact be perceived as facilitative
(i.e., helpful) for one’s efforts [21,23,25,26]. Previous public speaking anxiety treatments have
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been effective in reducing, but not completely eliminating, public speaking anxiety, and in
light of the reappraisal literature that highlights individuals’ ability to perceive anxiety in a
favorable light, it is important that researchers devise methods that not only help with anxiety
reduction, but also assist participants in reinterpreting their remaining nerves more positively.
Inoculation Theory: A Framework for Reducing and Reframing Anxiety?
Inoculation theory is a well-established framework [27,28] for helping individuals withstand
attacks or challenges to existing attitudes, beliefs, or states. Developed out of research on the
effectiveness of two-sided messaging (i.e., messages in which arguments in favor of, and
opposing, a source’s position are presented [29]), inoculation theory is a resistance-based
model that has its roots in a medical analogy. Specifically, medical immunization works
through an adaptation process that occurs following exposure to a weakened form of a virus,
thus rendering the host immune to future, stronger strains of the virus. Operating at a psycho-
logical level in much the same way, it was proposed within inoculation theory that when indi-
viduals are (a) warned of an impending threat to their current position or perception, (b)
provided with examples of potential forthcoming challenges to that position/perception (i.e.,
counterarguments), and (c) given refutations to those arguments, this may help the individual
retain his/her original position should those (or other) challenges actually occur in the future.
For example, in seeking to protect individuals’ anti-alcohol attitudes, inoculation message
designers might first warn recipients that they may be challenged on their stance (e.g., “there
may be people who try to convince you that excessive alcohol consumption isn’t so bad after
all”), before then providing the recipient with examples of likely challenges (e.g., “your friends
might tell you that drinking alcohol in excess is safe and fun. . .”), and refutational material
that explains why the recipient’s position should not be altered by those challenges (e.g.,
“. . .but, there are well-documented dangers associated with excessive alcohol consumption”).
Inoculation messages have been used to successfully protect a range of important perceptual
variables in health (e.g., anti-smoking and -alcohol beliefs; for a comprehensive review of
health inoculation strategies [30]) and physical performance [31,32] domains, among other
contexts.
There is also evidence that inoculation may be used to protect against undesired future
states (e.g., feelings, cognitions). For example, Richards and Banas [33] used an inoculation
strategy to protect against feelings of reactance (i.e., feeling one’s freedoms are threatened) that
may be stimulated through the receipt of persuasive health messages (e.g., “don’t tell me not to
smoke, I’ll do what I want”). In their inoculation treatment, recipients were explicitly warned
that they may be prone to experiencing reactance following the receipt of a message encourag-
ing the avoidance of binge drinking (i.e., “you might feel that your freedom to choose how you
will consume alcohol is being threatened”). Subsequently, recipients were provided with refu-
tational information designed to allay such responses (i.e., “However, the facts about binge
drinking that are reported are pretty powerful when you think about them, and the suggestions
that are proposed about drinking responsibly actually make a lot of sense”).
In relation to the aims of the present study, therefore, it could be theorized that a message
developed using inoculation theory principles might help ‘protect’ speakers against the onset
of anxiety, and against negative interpretations regarding the effects of anxiety. In that sense,
the ‘resistance’ aspect of inoculation theory, in this instance, refers to individuals’ ability to
resist the onset of debilitating anxiety prior to and during a public speaking activity (i.e.,
retaining a calm, controlled state). An inoculation message to protect individuals in this con-
text, therefore, would include a threat-inducing forewarning about the anxiety that public
speaking may invoke (e.g., “many presenters become nervous prior to, and during, speaking in
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public”), material that highlights the specific concerns that individuals may face (e.g., “you
may worry that everyone can see how anxious you are”), and finally, information that helps
the recipient overcome, cope with, or more positively interpret those specific concerns (e.g.,
“don’t worry, because in fact, people will not be able to gauge your nerves very well”).
Although inoculation messages have, until now, not been used with the aim of protecting indi-
viduals against debilitating anxiety experiences, they offer a standardized, theory-driven
method that is suitable for mass dissemination. As a result, this method enabled us to address
a number of the treatment design considerations highlighted previously. Similarly, although
reappraisal research using public speaking activities [21,25] supports the notion that partici-
pants can interpret a given level of anxiety in more or less adaptive ways, little attention has
been directed toward studying the utility of reappraisal methods (a) based on inoculation mes-
sage principles, (b) among non-clinical samples, or (c) when performing a ‘real-world’ activity
—in front of a relatively large audience—that participants have been aware of (and able to pre-
pare for) over a period of weeks (rather than a brief preparation period ahead of a laboratory-
based task).
The aim of this experiment was to assess the effect of an inoculation message, relative to a
neutral control message, on individuals’ anxiety-related perceptions immediately prior to, and
during, a public speaking activity. As such, our aim was not to test the efficacy of an inocula-
tion message in improving recipients’ public speaking performance per se; rather, we sought to
determine whether an inoculation message—delivered prior to a public speaking engagement
—may facilitate recipients’ emotions and interpretations relating to the speech. Prior to the
task, we measured individuals’ social anxiety (i.e., their fear of negative audience evaluation),
general anxiety about the upcoming speech, and their self-efficacy (i.e., their confidence in
their ability regarding their speech). We measured self-efficacy alongside anxiety perceptions
due to previous public speaking work that has demonstrated an inverse association between
anxiety and self-efficacy, and has reported an efficacy-enhancing effect of anxiety reduction or
reappraisal treatments [12,21]. Following the task, participants reported the level of worry
(cognitive anxiety) and somatic anxiety they had experienced during the task, their interpreta-
tions of their anxiety, and the self-talk that they employed during the activity. We measured
anxiety magnitude and interpretations in light of the anxiety-focused nature of the message,
and included assessment of self-talk as evidence indicates that changing participants’ self-state-
ments is an important part of an effective public speaking anxiety-reduction treatment [13]. In
line with the findings for previous public speaking anxiety treatments [9], and the effectiveness
of inoculation messages for protecting recipients’ perceptions [30], we hypothesized that those
who received an inoculation message—relative to an information-only control message—
would report lower anxiety levels, more facilitative (as opposed to debilitative) interpretations




Upon receiving ethical approval to conduct the study from The University of Western Austra-
lia Human Research Ethics Committee (RA/4/1/6754), participants were recruited from an
undergraduate kinesiology class at the lead author’s institution, and participation was volun-
tary in return for class credit. Data collection took place over two years; all members of the
2014 and 2015 cohorts were invited to participate in the study. The final sample—excluding
those who enrolled in the study but subsequently failed to undertake the public speaking
task (n = 5; students who withdrew from the class during the semester)–consisted of 230
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undergraduates (Mage = 20.14, SD = 2.72), who were cluster randomized (by year group) into
control (n = 128, Mage = 19.92, SD = 2.22, 60 males, 68 females) or treatment (n = 102, Mage =
20.41, SD = 3.23, 50 males, 52 females) conditions. In terms of participants’ GPA, those in the
control treatment had a mean GPA on entering the class of 5.13 (SD = 0.83, range = 2.25 to
6.75), and those in the treatment condition had a mean GPA on entering the class of 5.33
(SD = 0.97, range = 2.69 to 7.00). The sample size exceeded that which was indicated as part of
an a priori sample size estimation (i.e., approximately 50–60 participants per cell) based on
existing meta-analytic evidence for the magnitude of inoculation effects [34]. Students who
undertook the class in 2014 were assigned to the control condition, and those who took the
class in 2015 were assigned to the treatment condition. The decision to cluster randomize,
rather than randomly assigning individuals within each year group, was made on the grounds
that we sought to avoid the significant threat to validity associated with word-of-mouth con-
tamination effects that would arise if those in the treatment condition were able to discuss the
message with those in the control condition. In order to standardize the task across years, par-
ticipants in the control and treatment conditions were assigned the exact same topics for their
speeches (all speeches were based on a study that had been conducted earlier in the semester
and that remained identical between 2014 and 2015), and all requirements of the activity were
held constant across both years (e.g., assessor, group size, audience size, location). Prior to
their involvement in the study, participants had received no formal public speaking training as
part of their university degree.
In the first week of the 13-week semester, participants were informed by their lecturer that,
as part of the class requirements, they would perform a 30-minute group-based speech/presen-
tation in front of approximately 20 of their classmates. It is important to clarify that although
participation in the speech was a class requirement, participation in the research procedures
associated with the speech (i.e., questionnaire completion, message receipt) was voluntary. In
an attempt to minimize the effects associated with being able to choose one’s group members
and presentation slot (e.g., one’s anxiety being influenced by working with, or presenting in
front of, one’s friends), participants were randomly assigned to a presentation group consisting
of four presenters, and to a presentation slot between week 9 and 12 of the semester. Presenta-
tions were scheduled in a group-based format due to logistical reasons (i.e., fitting all presenta-
tions in during the allotted time period); however, participants were informed that their
performance as an individual would be assessed by an instructor (who was blind to the study
protocol and aims). Participants were also informed that they should split the speaking
requirements evenly between all group members. As a result, although each group prepared
for a 30-minute speech, individual group members spoke for approximately 8 minutes, and
were made aware that they would be assessed on an individual basis regarding their perfor-
mance during that period.
Having provided their written consent to participate in the research, two weeks prior to
their presentation date, participants were provided with a hard copy information sheet from
the lecturer that contained the control or treatment material. Participants were instructed to
read the information sheet, and three days prior to their presentation, they were electronically
provided with the same information sheet. The decision to provide the information sheet in
advance of the presentation was taken on the basis that public speaking anxiety peaks immedi-
ately prior to an activity [35], and so we provided the material in advance of this period so as
to ensure that participants were not so anxious/threatened [36] that they would be unable to
attend fully to the content of the message. On the basis of their response to a screening ques-
tion provided at the close of data collection, all participants verified that they had read the
information provided. Immediately before and after their presentation, participants were
asked to complete a series of questionnaires. It was not until data collection was completely
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terminated that all participants were presented with complete information about the true aims
of the study (and those in the control group were provided with a copy of the inoculation
treatment).
Experimental Manipulation
Participants in the control condition received a generic one-paragraph information sheet that
detailed the requirements of the activity, the nature of the assessment, the implications of their
performance for their overall class grade, and wished them luck with their speech. Within the
treatment condition, alongside the generic information that was presented to those in the con-
trol group, participants were provided with additional material derived in line with principles
of inoculation theory (see S1 File). First, participants were provided with a forewarning regard-
ing the anxiety that they may experience. Following this forewarning, participants in the
treatment condition were presented with three counterarguments and paired (i.e., passive) ref-
utations that targeted common preconceptions and anxiety-inducing concerns related specifi-
cally to public speaking (for support [2,16,37]). The first counterargument-refutation pairing
was designed to highlight and address fears related to the ‘visibility’ of one’s anxiety, and
focused specifically on reassuring individuals regarding the illusion of transparency. The sec-
ond pairing focused on highlighting and alleviating concerns relating to the extent to which
one would be scrutinized by the audience (i.e., the spotlight effect [38]), and the final pairing
focused on drawing participants’ attention to (and minimizing concerns regarding) the detri-
mental effects that anxiety may have on their performance. This final pairing was designed to
inform individuals that anxiety may not necessarily be damaging to their performance, and
need not be interpreted in a debilitative manner. To strengthen the refutational claims, cita-
tions to empirical evidence were included (for the interested reader, these references are listed
in S1 File), and the writing emphasized the relevance of the material for the participants’
speaking performance.
Measures
Background variables and inoculation components: Personality traits. In order to
obtain a brief assessment of personality traits, participants completed a brief version of the Big
Five Inventory (BFI-10 [39]) during the first week of the semester. Participants responded to
the stem, “I see myself as someone who. . .”, and the BFI-10 contains two items for each of the
Big Five traits, namely agreeableness (e.g., “is generally trusting”), conscientiousness (e.g.,
“does a thorough job”), extraversion (e.g., “is outgoing, sociable”), neuroticism (e.g., “gets ner-
vous easily”), and openness to experience (e.g., “has an active imagination”). The BFI-10 has
been widely used for the purpose of brief personality assessment, and support for the validity
and reliability of scores derived from the BFI-10 has been reported previously [39,40]. Com-
monly-used reliability estimators are not recommended as a criterion for judging the reliability
of BFI-10 subscales, given that the items within each scale are designed to broadly cover the
personality dimension in its entirety (rather than to assess the same facet within any given
dimension [40]). Purely for information purposes, though, and given that each subscale con-
sists of two items, we did calculate Spearman-Brown coefficients (ρ) for agreeableness
(ρ = .33), conscientiousness (ρ = .47), extraversion (ρ = .71), neuroticism (ρ = .57), and open-
ness (ρ = .39). Despite the relatively low internal consistency estimates observed for some sub-
scales, we retained the BFI-10 scores on the basis of the conceptual argument presented above.
Background variables and inoculation components: Perceived threat. Consistent with
previously-reported measurement procedures [31], one item was used to assess participants’
perceptions of threat relating to the speaking activity. Participants were asked to respond to
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the statement, “Thinking about the upcoming presentation, I view the prospect of challenges
to my ability to present well as. . .”, using a bipolar response scale anchored at 1 (unlikely) and
7 (likely). The use of a single threat item was advantageous in order to limit overall question-
naire length, given that participants were asked to complete threat, importance, and pre-task
measures immediately prior to their presentation.
Background variables and inoculation components: Task importance. Participants
rated the importance of the speaking task using a single item (“It is important to me to do well
in my presentation”), anchored at 1 (not at all true) and 7 (very true).
Pre-task perceptions: Social anxiety. Participants completed a revised version of an exist-
ing four-item instrument [41], which was designed to measure their anxiety regarding the way
in which they would be evaluated by their classmates (i.e., the audience). Following the stem,
“right at this moment in time, thinking about this presentation. . .”, participants responded to
statements including, “I am concerned about embarrassing myself in front of the audience”,
and “I am concerned that the audience will think I am a poor presenter”. Minor modifications
were made to the original items in order to focus participants’ attention toward their audience,
and the original response scale, anchored at 1 (not at all) and 5 (extremely), was used. The
internal consistency of the measure derived from this instrument in this study was α = .87.
Pre-task perceptions: Task-related anxiety. Participants responded to a single item
assessing the degree to which they were anxious about their presentation. Specifically, using a
5-point response scale ranging from 1 (not at all) to 5 (a great deal), participants were asked,
“overall, how nervous or anxious do you feel right now about your presentation today?”
Pre-task perceptions: Self-efficacy. Consistent with self-efficacy scale construction
guidelines [42], we assessed participants’ confidence in their ability regarding their speech
with items that were devised to represent the primary tasks required of them during their pre-
sentation. Using an established response scale [43] ranging from 1 (no confidence at all) to 5
(complete confidence), participants were provided with four items (i.e., “control your nerves at
all times”, “speak clearly at all times”, “maintain audience interest at all times”, and “deal well
with any audience questions”) following the stem, “right at this moment in time, how confi-
dent are you in your ability to. . .”. The internal consistency of self-efficacy measure derived
from this instrument was α = .75.
Retrospective assessment of in-task perceptions: Cognitive and somatic anxiety.
Immediately following the task, and without having received any evaluative feedback regard-
ing their performance, participants were asked to report the degree of cognitive and somatic
anxiety they had experienced during the presentation by completing the five-item somatic
anxiety subscale and a modified version of the five-item worry (i.e., cognitive anxiety) subscale
from the Sport Anxiety Scale-2 (SAS-2 [44]). We recognize that the SAS-2 was developed to
assess worry and somatic anxiety with respect to sporting performance contexts; however,
upon inspection, the items within these subscales appeared to be either directly applicable (i.e.,
in the case of somatic anxiety; example items, “my body felt tense”, “my stomach felt upset”)
or modifiable (i.e., worry; example revised items, “I worried that I would not present well”,
“I worried that I would mess up during the presentation”) for the performance of public
speaking.
Prior to deciding to use this instrument, we conducted a thorough literature search that
revealed no established instrument specific to public speaking that fit our measurement crite-
ria. As a result, although the SAS-2 was developed for a different context, we selected this
instrument in light of a number of considerations. In particular, in comparison to instruments
specific to public speaking anxiety that have been used previously [45–47], the benefits of
using the modified SAS-2 were that it provided the opportunity to assess performance-related
anxiety (a) using a brief, validated instrument, (b) in relation a specific activity (i.e., we
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required a situation-specific measure), (c) with respect to an activity performed alongside oth-
ers (e.g., worry item, “I worried that I would let others down”), and (d) using a measure that
separately assessed cognitive and somatic dimensions of anxiety. In addition, instruments
prominently used to measure anxiety (e.g., Beck Anxiety Inventory [48]) or social anxiousness
(e.g., Interaction Anxiousness Scale [49]) were also unsuitable given their clinical or trait-like
assessment method, and their inability to be modified easily to suit public speaking situations.
In order to obtain retrospective ratings, participants were requested to respond to all state-
ments by circling the number that best represented how they felt during their presentation,
and in line with original scoring procedures, a response scale ranging from 1 (not at all) to 4
(verymuch) was employed. The use of retrospective assessments to assess one’s anxiety levels is
well established within the public speaking literature [13,50]. Support for the reliability and
structural properties of measures derived from the SAS-2 has been reported [44], and amended
versions of the SAS-2 have been shown to be appropriate for use in contexts other than sport
[51]. The internal consistency for measures derived from the worry (α = .91) and somatic anxi-
ety (α = .90) subscales were acceptable in this investigation.
Retrospective assessment of in-task perceptions: Interpretation of anxiety. Consistent
with recommendations [52] and with previously-used measures of anxiety/emotion direction
[53,54], participants were asked to reflect how, on the whole, they felt their nerves/anxiety had
influenced their presentation performance. Using a scale anchored at -3 (strong negative
impact), 0 (no impact at all), and 3 (strong positive impact), participants responded to the item,
“overall, how do you feel your nerves or anxiety impacted on how well you were able to present
today?” As a result, a higher score on this index indicated that participants perceived their anx-
iety to be more facilitative for their speaking performance.
Retrospective assessment of in-task perceptions: Impact of message. In order to iden-
tify whether individuals’ anxiety interpretation was influenced directly by the message (i.e.,
information sheet) they received, participants responded to a single item (“overall, what
impact did the information sheet you received have on the way you viewed your nerves or anx-
iety about your presentation?”), using a response scale anchored at -3 (it made me more wor-
ried about being nervous), 0 (it had no impact on my interpretation of my nerves), and 3 (it made
me less worried about being nervous). Accordingly, a higher score on this measure indicated
that participants felt the message had enabled them to interpret their nerves/anxiety more
positively.
Retrospective assessment of in-task perceptions: Self-talk. The final instrument that
participants completed following their presentation was the Self-Statements during Public
Speaking (SSPS) scale [55]. The 10-item SSPS scale comprises two five-item subscales that
allow researchers to retrospectively assess individuals’ positive (e.g., “I can handle everything”)
and negative self-statements (e.g., “what I say will probably sound stupid”) during a public
speaking task. Participants were instructed, “The statements below cover some of the things
that you may have felt and thought to yourself during your presentation. Reflecting on how
you felt and thought to yourself during your presentation, how much do you agree with each
of the statements provided below?” Consistent with the original scoring procedures, responses
were made on a 6-point scale anchored at 0 (do not agree at all) and 5 (agree extremely), and
higher scores for each subscale represent greater positive/negative self-statements. Support for
the structural properties, internal consistency, and test-retest reliability of measures derived
for both SSPS subscales has been reported [55]. In the present study, we observed an acceptable
level of internal consistency for the negative self-statements subscale (α = .82); however, the
internal consistency of the positive self-statements subscale (α = .66) was marginal, and so (on
conservative grounds) we excluded this subscale from further analyses.
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Results
A missing value analysis on all primary variables was conducted using IBM SPSS (Version
22.0), and indicated that the missing data (which represented less than 0.1% of the overall data
file) were missing completely at random; Little’s chi-square test [56] was nonsignificant,
χ2(877) = 834.87, p = .84, and missing data were imputed using the expectation maximization
procedure. For the data file used in the analyses reported below, see S2 File.
Preliminary Analyses
Prior to testing for between-condition differences on threat and task importance, and in light
of the cluster randomization method that we employed, we sought to rule out there being any
potential demographic differences between the two cohorts. A chi-square test of association
for gender-by-condition revealed no significant effect, χ2(1) = .10, p = .75, indicating that the
proportion of males-to-females was consistent between years (i.e., between those assigned to
control versus treatment conditions), and a one-way ANOVA indicated no significant age dif-
ference between participants in the two conditions, F(1, 228) = 1.85, p = .18, η2p = .008.
In addition to checking for demographic differences, we also tested for potential back-
ground differences in terms of participants’ personality traits and GPA between years (i.e.,
their GPA on entering the class). A one-way MANOVA, in which GPA and Big Five personal-
ity scores were treated as dependent variables (i.e., 6 dependent variables), and condition (i.e.,
control vs. treatment) was the independent factor, revealed a nonsignificant multivariate effect,
F(6, 211) = 1.69, p = .12, η2p = .05, λ = .95. As would be expected from this multivariate effect,
at the univariate level there were no significant differences using a Bonferroni-adjusted alpha
level for multiple comparisons (i.e., .05/6 = .008). However, in light of the significance level
that we observed for the between-condition difference on extraversion, F(1, 216) = 4.34, p =
.038, η2p = .02 (Mcontrol = 3.52, SDcontrol = .82; Mtreatment = 3.28, SDtreatment = .94, on a 1-to-5
scale), and given the relevance of extraversion for one’s reactions to social evaluative activities
[57], we adopted a conservative approach and included extraversion as a covariate when exam-
ining subsequent between-condition differences.
To examine between-condition differences on perceptions of threat and task importance
(measured prior to the activity), we ran a one-way MANCOVA, with condition as the inde-
pendent factor, threat and importance as dependent variables, and extraversion as a covariate.
Descriptive data for these and all other variables—separated by condition—are displayed in
Table 1. The analysis revealed a significant multivariate effect for condition, F(2, 226) = 7.87,
p< .001, η2p = .06, λ = .93. Using a Bonferroni-adjusted alpha criterion at the univariate level
in light of multiple comparisons (i.e., .05/2 = .025), the multivariate effect was accounted for
by significant differences on perceived task importance, F(1, 227) = 14.45, p< .001, η2p = .06.
Specifically, although both groups of participants endorsed strong absolute perceptions of task
importance, participants in the treatment condition reported greater perceptions of impor-
tance relative to those in the control condition (see Table 1). For this reason, we entered task
importance as a covariate in subsequent analyses, alongside extraversion. Univariate follow-
ups revealed no significant difference for threat perceptions between conditions, F(1, 227) =
0.33, p = .57, η2p = .001.
Main Analyses
Pre-task perceptions. In light of the gender differences that have been reported previ-
ously for public speaking anxiety prevalence [5], when examining potential between-condition
differences on variables measured before the speaking performance, we accounted for gender
by performing a two-way MANCOVA, with gender and condition as independent factors. We
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included extraversion and task importance as covariates in our analyses, and entered partici-
pants’ social anxiety, task-related anxiety, and self-efficacy as dependent variables. Our analy-
ses revealed significant multivariate main effects for condition, F(3, 222) = 5.01, p = .002, η2p =
.06, λ = .94, and gender, F(3, 222) = 4.63, p = .004, η2p = .06, λ = .94, but no multivariate inter-
action effect, F(3, 222) = 1.29, p = .28, η2p = .02, λ = .98. We followed up the condition and gen-
der main multivariate effects using an adjusted alpha criterion at the univariate level in light of
multiple comparisons (i.e., .05/3 = .017), and identified that the condition effect was accounted
for by significant between-condition differences in terms of participants’ task-related anxiety,
F(1, 224) = 13.00, p< .001, η2p = .06, but not social anxiety, F(1, 224) = 5.05, p = .026, η2p =
.02, or self-efficacy, F(1, 224) = 0.53, p = .47, η2p = .01. Relative to their counterparts in the con-
trol condition, those who received the inoculation treatment reported significantly lower anxi-
ety regarding their speaking performance (see Table 1). The univariate significance level for
participants’ social anxiety was below .05; however, this difference was not significant when
accounting for the adjusted alpha criterion. In absolute terms, the mean between-condition
differences on social anxiety and task-related anxiety were 0.26 and 0.38, respectively (on a
1-to-5 scoring scale).
The multivariate effect that we observed for gender—although not substantively important
for the purpose of the investigation—was accounted for by significant differences between
males’ and females’ social anxiety, F(1, 224) = 10.89, p = .001, η2p = .05, task-related anxiety,
F(1, 224) = 9.27, p = .003, η2p = .04, and self-efficacy, F(1, 224) = 10.76, p = .001, η2p = .05. In
particular, prior to the speaking task, females on average reported greater social and task-
related anxiety, and lower self-efficacy, compared to males. For clarity, males reported mean
scores for social anxiety, task-related anxiety, and self-efficacy of 2.90 (SD = 0.90), 3.40





Between-condition effect size (d)
M SD M SD
Inoculation components
Threat 4.40 1.38 4.53 1.18 .10
Task importance 6.40 .75 6.04 .83 .46
Pre-task perceptions
Social anxiety 2.95 .93 3.21 .94 .28
Task-related anxiety 3.36 .88 3.74 .87 .43
Self-efficacy 3.01 .66 2.89 .67 .18
Task perceptions
Cognitive anxiety/Worry 2.32 .75 2.56 .76 .32
Somatic anxiety 1.90 .70 2.18 .78 .38
Interpretation of anxiety -.37 1.18 -.73 1.03 .32
Impact of message .52 .97 -.02 .84 .60
Negative self-talk .97 .82 1.23 .93 .30
Note. Threat and importance measured 1–7, where higher scores denote greater threat/importance. Social
anxiety, task-related anxiety, and self-efficacy measured 1–5, where higher scores denote greater anxiety/
confidence. Cognitive and somatic anxiety rated 1–4, where higher scores denote greater anxiety.
Interpretation of anxiety and impact of message rated -3 to 3, where positive (negative) scores denoted a
more positive (negative) interpretation of anxiety/impact of message. Negative self-talk measured 0–5,
where higher scores denote greater negative self-talk. d column = Cohen’s d effect size estimate for mean
between-condition comparison on each primary variable.
doi:10.1371/journal.pone.0169972.t001
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(SD = 0.84), and 3.08 (SD = .60), respectively. Females reported mean scores for social anxiety,
task-related anxiety, and self-efficacy of 3.28 (SD = 0.94), 3.73 (SD = 0.91), and 2.82 (SD = .70),
respectively.
Task perceptions. Our final analytic procedure focused on examining potential condi-
tion- and gender-related differences on variables relating to participants’ experiences during
their presentation. To do so, we performed a two-way MANCOVA, with gender and condition
as independent factors, extraversion and task importance as covariates, and participants’ (a)
cognitive anxiety/worry, (b) somatic anxiety, (c) interpretation of their anxiety, (d) perception
of the impact of the message on their anxiety, and (e) negative self-talk, as separate dependent
variables. Analyses revealed a significant multivariate main effect for condition, F(5, 220) =
5.15, p< .001, η2p = .10, λ = .90, alongside a nonsignificant multivariate main effect for gender,
F(5, 220) = 2.12, p = .06, η2p = .05, λ = .95, and a nonsignificant multivariate gender-by-condi-
tion interaction, F(5, 220) = 0.63, p = .68, η2p = .01, λ = .99.
Univariate follow ups, using an adjusted alpha criterion in light of the multiple comparisons
(i.e., .05/5 = .01), revealed that the main effect for condition was accounted for by differences
on somatic anxiety, F(1, 224) = 7.37, p = .007, η2p = .03, and the perceived effect of the informa-
tion sheet on how participants viewed their nerves, F(1, 224) = 17.81, p =< .001, η2p = .07.
Specifically, participants who received the inoculation treatment reported reduced somatic
anxiety and felt that the information sheet (i.e., message) was responsible for making them less
concerned about their anxiety (i.e., it made them less worried about being nervous), relative to
those in the control condition (see Table 1). In absolute terms, the mean between-condition
difference on somatic anxiety was 0.28 (on a 1-to-4 scoring scale), and the mean difference for
message impact—scored from -3 to 3 –was 0.54. The univariate significance level of the differ-
ences on cognitive anxiety/worry, F(1, 224) = 5.90, p = .016, η2p = .03, and participants’ inter-
pretation of their anxiety, F(1, 224) = 4.94, p = .027, η2p = .02, was also below .05; however,
these differences were not significant when accounting for the adjusted alpha criterion. The
univariate significance level for the remaining variable in the model, namely negative self-talk,
was F(1, 224) = 3.44, p = .065, η2p = .02. Zero-order correlations between all primary variables
are presented in Table 2.
Table 2. Aggregate-level skewness, kurtosis, and zero-order correlations for all variables (including GPA) across the entire sample.
Variable Skew. Kurt. 2 3 4 5 6 7 8 9 10 11
1. GPA -.44 -.05 -.05 .09 .01 -.05 .19** -.09 -.09 .10 .08 -.14*
2. Threat -.37 -.01 - .15* .13 .11 .12 .15* .12 .02 -.01 .06
3. Task importance -.83 .18 - -.07 -.01 .26*** -.06 -.08 .12 .05 -.18**
4. Social anxiety -.04 -.55 - .69*** -.65*** .66*** .55*** -.18** -.16* .54***
5. Task-related anxiety -.17 -.52 - -.53*** .57*** .59*** -.23*** -.22** .39***
6. Self-efficacy -.59 .09 - -.54*** -.43*** .27*** .13* -.48***
7. Cognitive anxiety/Worry .28 -.73 - .65*** -.35*** -.20** .66***
8. Somatic anxiety .69 -.35 - -.25*** -.05 .46***
9. Interpretation of anxiety .71 .03 - .20** -.25***
10. Impact of message .29 .86 - -.10
11. Negative self-talk .70 -.07 -
Note.
* = p < .05;
** = p < .01;
*** = p < .001.
doi:10.1371/journal.pone.0169972.t002
Anxiety Inoculation
PLOS ONE | DOI:10.1371/journal.pone.0169972 January 26, 2017 11 / 18
Discussion
The experience of anxiety when speaking in public is common and can be debilitating. Within
the communication apprehension literature, sustained research attention has been targeted
toward identifying and treating the causes of this form of social anxiety [8]. Guided by research
on public speaking anxiety treatment effectiveness, and by cross-disciplinary knowledge about
the nature of performance anxiety, we tested an inoculation message that was designed to not
only alleviate individuals’ speech-related anxiety, but also to enable them to interpret any
residual nerves in a more positive manner. In doing so, this investigation used established per-
suasion (i.e., inoculation theory) principles to explore the effects of an anxiety-alleviating mes-
sage on participants’ cognitive and somatic anxiety, as well as their appraisals about the effects
of anxiety for their performance capabilities. Relative to recipients of an information-only con-
trol message, participants who received the inoculation treatment reported lower task-related
anxiety prior to their speech, along with lower retrospective ratings of in-task somatic anxiety.
Inoculated participants also reported that the message they received contributed to them being
less concerned about their anxiety.
On a practical level, this study presents a novel, standardized, and easy to disseminate
method for alleviating a highly prevalent form of anxiety. Individuals who are highly anxious
about public speaking display greater self-focused, negative attention during speaking, as well
as poorer speaking performance [58]. From a more holistic perspective, high levels of public
speaking anxiety have, in some instances, also been shown to accompany other mood and/or
anxiety disorders [4], an aversion to group and dyadic interaction [59], and problems in
employment, educational, and social situations [5]. The practical significance of successful
public speaking anxiety treatments, therefore, is underscored by the potential to (at least par-
tially) offset this adverse affective and behavioral profile.
It is important to also highlight, however, that public speaking anxiety treatments—includ-
ing the present study—are typically successful only in reducing (and not completely eliminat-
ing) presenters’ anxiety. For that reason, we also sought to examine whether an inoculation
message may hold additional promise for modifying recipients’ interpretations of their remain-
ing nerves. When examining differences on our ‘anxiety interpretation’ outcome within a mul-
tivariate framework (i.e., when adjusting for multiple comparisons), we did not find evidence
of a significant interpretational effect (i.e., the univariate p value for the between-condition dif-
ference test was .027). Nonetheless, the effect size (Cohen’s d, illustrated in Table 1) for this
between-condition difference did demonstrate evidence of a small-to-medium-sized effect,
offering some insight relating to—and encouragement for future research aimed at examining
—the potential effectiveness of inoculation messages for anxiety reappraisal with non-clinical
samples performing ‘real-world’ activities (i.e., that participants had prepared for over a period
of weeks, and that was performed in front of a relatively large audience). In support, partici-
pants in the inoculation treatment condition—relative to those in the control condition—did
report that the information they received (i.e., the inoculation, relative to control, message)
made them significantly less ‘worried’ about any nerves that they carried into the speech.
An important practical conclusion emerging from these findings is that the relatively lower
anxiety levels among inoculation participants occurred whilst including respondents’ person-
ality traits as a covariate, and without weakening perceptions about the importance of the
activity. It might have been argued that the ‘reassuring’ nature of the inoculation treatment
could have reduced speech anxiety simply by acting to allay perceptions about the significance
or importance of the activity. It is noteworthy, therefore, that those who received the inocula-
tion (relative to control) message actually reported significantly greater task importance, a per-
ception that typically accompanies heightened (not reduced) anxiety [60,61]. For that reason,
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it is noteworthy that the treatment effect was observed for anxiety levels (i.e., pre-speech task-
related anxiety and in-task somatic anxiety) whilst accounting for task importance as a covari-
ate in our analyses.
As well as considering issues of practical significance, it is important to reflect on the con-
ceptual contribution of these findings. Most notably, this study emphasizes the potential appli-
cability of inoculation theory. Inoculation messages have traditionally been used with the goal
of fostering attitudinal protection (i.e., instrumental, value-based judgments), and have been
demonstrated to be efficacious in conferring resistance with this target construct [34]. Recent
research indicates, however, that inoculation techniques may also be effective for inducing
resistance in the face of attacks/challenges to other psychosocial variables, including agentic
perceptions such as self-efficacy [31]. These findings highlight that the ‘reach’ of inoculation
may also extend to the protection of emotional states, and may provide the foundation for
charting inoculation’s effectiveness in terms of affective dimensions of resistance (e.g., enjoy-
ment, interest [28,32]).
The abovementioned findings were consistent with our a priori hypothesis; however, we
did fail to detect between-group differences on some primary variables. Specifically, we
observed no significant difference between inoculation and control participants’ pre-task self-
efficacy. As would be expected according to principles of self-efficacy theory [62], higher pre-
task self-efficacy perceptions were significantly and negatively correlated with all anxiety indi-
ces. However, the treatment did not induce stronger self-efficacy perceptions among inocula-
tion (relative to control) participants. Similarly, although we observed effect sizes that
indicated a small-to-moderate effect (and a significance value for cognitive anxiety that would
have been interpretable were it not for our adjusted criterion), there were no significant differ-
ences between groups in terms of task-related cognitive anxiety/worry and negative self-talk.
As such, although there may be merit in considering worry- and self-talk-related effects of
inoculation treatments in future, out findings preclude any inferences relating to the effective-
ness of inoculation on these differences. It is difficult to interpret these non-significant find-
ings without relying on speculative (i.e., not data-driven) explanations. Nonetheless, it may be
noteworthy that each of these variables is primarily cognitive (as opposed to affectively-laden)
in nature, and so it may be possible that the treatment acted more powerfully on affective con-
cepts. That being the case, it would be interesting in future to include additional counterargu-
ment-refutation pairings in treatments such as this that specifically target self-doubt and
counterproductive self-talk.
It is also worth considering why the inoculation group failed to experience more threat
than the control condition, as would be consistent with most inoculation research and the
assumptions of the theory. Previous inoculation studies have provided evidence of resistance
in the absence of significant differences in threat between the control and experimental group
[63], pointing to other processes, besides threat and counterarguing, that are at work in inocu-
lation-conferred resistance. Indeed, it is possible that, despite not being forewarned about the
likely challenges they may face during their presentation, those in the control group were—
due to their previous experience of speaking in public—still cognizant of the nerves and diffi-
culties that accompany such a performance. Alternatively, although our single-item measure
of threat tapped into participants’ awareness of impending challenge, it did not assess their
perceived vulnerability to those challenges. This measurement approach was most efficient in
terms of time demands, but in future it may be worthwhile to also measure individuals’ per-
ceived vulnerability toward succumbing to the threat [28].
It is important to balance the novel aspects and contribution of this study against design
limitations and opportunities for advancement of the work. For example, in light of time
restraints it was necessary to utilize single-item assessments for some constructs (e.g., anxiety
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interpretation, pre-speech task-related anxiety). We observed associations between these mea-
sures and relevant correlates that were largely consistent with theory; however, in future it may
be advisable to incorporate multi-item assessments where possible. In addition, we evaluated
the efficacy of this treatment using a single performance scenario, and as a result we were
unable to test some valuable inoculation processes. For example, inoculation scholars have
demonstrated the potential for inoculation effects to persist over-time [64], and that treat-
ments on a given issue may confer cross-protection for related issues/attacks [65]. These con-
siderations encourage further research that examines (a) whether the acute anxiolytic effects
we observed may be retained over time, and (b) if the public speaking treatment that we
employed—or a modification thereof—might provide ‘umbrella’ protection against anxiety in
other stress-inducing scenarios (e.g., test-taking, job interviews, sport competition).
On a separate issue, although our aim was to capture participants’ self-report anxiety levels,
it would have been informative had we supplemented our respondent ratings with heart rate
data, physiological markers [24,25], or audience perceptions [21], to examine both the internal
and the overt behavioral signatures that accompany this form of anxiety [8]. Indeed, a more
comprehensive approach such as this would enable future assessment to be more consistent
with the longstanding notion that one’s emotional responses (such as anxiety) can be mea-
sured according to three systems—one’s affective reports (as we assessed in this study), one’s
physiological signals, and one’s overt behavioral responses [66,67]. The nature of the group-
based presentation format also has implications for future measurement considerations. Most
notably, despite participants being randomly assigned to groups, it may be valuable in future—
in cases where a group-based procedure is employed—to assess and control for relevant in-
group communicative and social factors (e.g., perceptions of support, cohesion) that might
shape presenters’ anxiety levels/interpretations.
It would also be valuable in future to compare the efficacy of different anxiety-focused inoc-
ulation treatments. To elaborate, two of the three counterargument-refutation pairings in our
message were focused on reducing the perceived demand placed on participants (i.e., through
material highlighting the illusion of transparency and spotlight effect), whereas the remaining
pairing provided information that was focused toward enhancing respondents’ perceived cop-
ing resources (i.e., the reappraisal material). In future, it would be worthwhile to more specifi-
cally compare the effectiveness of ‘demand minimization’ inoculation messages, in which the
aim is to alleviate anxiety, with ‘resource maximization’ messages, in which the aim is to help
individuals reappraise and more effectively manage their anxiety [21].
In conclusion, this study demonstrates that inoculation theory might provide a novel
approach for alleviating (aspects of) public speaking anxiety. Indeed, the standardized and
easy-to-disseminate messaging principles within inoculation treatments might make this a
particularly appealing approach given the widespread prevalence of public speaking anxiety.
In addition to offering a novel treatment strategy, this study also drew from the anxiety reap-
praisal literature [25] to demonstrate that it may be possible to help participants reframe as
well as reduce their apprehension about public speaking, and encourages future research that
establishes the scope and lasting effects of anxiety-focused inoculation. Although public speak-
ing is recognized as one of the foremost stress-inducing evaluative contexts, these findings
may help inform the treatment of acute anxiety across work, education, sport, music, theatre,
and social settings.
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